Self-StudyTreatment of Key Populations and Unique Situations
Treatment of Key Populations and Unique Situations
Sign In or Register to get started
Treatment of Key Populations and Unique Situations
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 2 Overview
Treatment of HCV in Persons with Renal Impairment - 0%Topic 1
BackgroundActivities- 0%Topic 2
HCV Treatment Studies in Persons with CKDActivities- 0%Topic 3
HCV Treatment in Persons with CKDTreatment of HCV in Persons with Renal Impairment Overview
About this Lesson
Last Updated: January 24th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: July 1st, 2015CNE and CME Review: February 14th, 2024CNE and CME Expiration: February 13th, 2027 (4th Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Treatment of HCV in Persons with Renal Impairment and available until February 14th, 2024.Learning Objectives
- Explain the impact of HCV on renal disease
- Summarize the main findings from HCV treatment studies in people with renal disease
- Discuss dosing of direct-acting antiviral medications in persons with chronic renal disease
- Describe appropriate HCV treatment in persons prior to renal transplantaton
- Summarize HCV treatment recommendations in persons following renal transplantation
Lesson Contributors
Authors
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneMaria A. Corcorran, MD, MPHMaria A. Corcorran, MD, MPH
Assistant Professor
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneQuick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
- 0%Topic 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-9e0a1e65-2024-12-09-232944